135 related articles for article (PubMed ID: 29904395)
1. Rapamycin provides anti-epileptogenic effect in a rat model of post-traumatic epilepsy via deactivation of mTOR signaling pathway.
Wang F; Chen F; Wang G; Wei S; Fang F; Kang D; Lin Y
Exp Ther Med; 2018 Jun; 15(6):4763-4770. PubMed ID: 29904395
[TBL] [Abstract][Full Text] [Related]
2. Pyrazolo[4,3-c]pyridine-4-one (PP-4-one) Exhibits Anti-Epileptogenic Effect in Rat Model of Traumatic Epilepsy by Mammalian Target of Rapamycin (mTOR) Signaling Pathway Downregulation.
Jin J; Shen X; Tian L; He G; Zhang Y
Med Sci Monit; 2020 Jul; 26():e923919. PubMed ID: 32687486
[TBL] [Abstract][Full Text] [Related]
3. The Role of Decreased Levels of Neuronal Autophagy in Increased Susceptibility to Post-traumatic Epilepsy.
Wang J; Chai X; Zhang F; Li Y; Shen H; Lu K
Neurochem Res; 2023 Mar; 48(3):909-919. PubMed ID: 36383323
[TBL] [Abstract][Full Text] [Related]
4. Effects of Rapamycin Treatment on Neurogenesis and Synaptic Reorganization in the Dentate Gyrus after Controlled Cortical Impact Injury in Mice.
Butler CR; Boychuk JA; Smith BN
Front Syst Neurosci; 2015; 9():163. PubMed ID: 26640431
[TBL] [Abstract][Full Text] [Related]
5. Prevention of post-ischemic seizure by rapamycin is associated with deactivation of mTOR and ERK1/2 pathways in hyperglycemic rats.
Yang X; Hei C; Liu P; Li PA
Biochem Biophys Res Commun; 2019 Nov; 520(1):47-53. PubMed ID: 31564412
[TBL] [Abstract][Full Text] [Related]
6. Effects of rapamycin and curcumin on inflammation and oxidative stress in vitro and in vivo - in search of potential anti-epileptogenic strategies for temporal lobe epilepsy.
Drion CM; van Scheppingen J; Arena A; Geijtenbeek KW; Kooijman L; van Vliet EA; Aronica E; Gorter JA
J Neuroinflammation; 2018 Jul; 15(1):212. PubMed ID: 30037344
[TBL] [Abstract][Full Text] [Related]
7. mTOR pathway inhibition as a new therapeutic strategy in epilepsy and epileptogenesis.
Citraro R; Leo A; Constanti A; Russo E; De Sarro G
Pharmacol Res; 2016 May; 107():333-343. PubMed ID: 27049136
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of mTOR Pathway by Rapamycin Decreases P-glycoprotein Expression and Spontaneous Seizures in Pharmacoresistant Epilepsy.
Chi X; Huang C; Li R; Wang W; Wu M; Li J; Zhou D
J Mol Neurosci; 2017 Apr; 61(4):553-562. PubMed ID: 28229367
[TBL] [Abstract][Full Text] [Related]
9. mTOR inhibition suppresses established epilepsy in a mouse model of cortical dysplasia.
Nguyen LH; Brewster AL; Clark ME; Regnier-Golanov A; Sunnen CN; Patil VV; D'Arcangelo G; Anderson AE
Epilepsia; 2015 Apr; 56(4):636-46. PubMed ID: 25752454
[TBL] [Abstract][Full Text] [Related]
10. Early molecular and behavioral response to lipopolysaccharide in the WAG/Rij rat model of absence epilepsy and depressive-like behavior, involves interplay between AMPK, AKT/mTOR pathways and neuroinflammatory cytokine release.
Russo E; Andreozzi F; Iuliano R; Dattilo V; Procopio T; Fiume G; Mimmi S; Perrotti N; Citraro R; Sesti G; Constanti A; De Sarro G
Brain Behav Immun; 2014 Nov; 42():157-68. PubMed ID: 24998197
[TBL] [Abstract][Full Text] [Related]
11. mTOR inhibition modulates epileptogenesis, seizures and depressive behavior in a genetic rat model of absence epilepsy.
Russo E; Citraro R; Donato G; Camastra C; Iuliano R; Cuzzocrea S; Constanti A; De Sarro G
Neuropharmacology; 2013 Jun; 69():25-36. PubMed ID: 23092918
[TBL] [Abstract][Full Text] [Related]
12. Impact of rapamycin on status epilepticus induced hippocampal pathology and weight gain.
Hester MS; Hosford BE; Santos VR; Singh SP; Rolle IJ; LaSarge CL; Liska JP; Garcia-Cairasco N; Danzer SC
Exp Neurol; 2016 Jun; 280():1-12. PubMed ID: 26995324
[TBL] [Abstract][Full Text] [Related]
13. Silent Information Regulator 1 Negatively Regulates Atherosclerotic Angiogenesis via Mammalian Target of Rapamycin Complex 1 Signaling Pathway.
Chen R; Huang Z; Wang J; Chen X; Fu Y; Wang W
Am J Med Sci; 2018 Aug; 356(2):168-176. PubMed ID: 30219159
[TBL] [Abstract][Full Text] [Related]
14. Influence of mTOR signaling pathway on ketamine-induced injuries in the hippocampal neurons of rats.
Liu FF; Zhao S; Liu P; Huo SP
Neurol Res; 2019 Jan; 41(1):77-86. PubMed ID: 30373500
[TBL] [Abstract][Full Text] [Related]
15. Mechanistic Target of Rapamycin Pathway in Epileptic Disorders.
Kim JK; Lee JH
J Korean Neurosurg Soc; 2019 May; 62(3):272-287. PubMed ID: 31085953
[TBL] [Abstract][Full Text] [Related]
16. Activation of mTOR signaling mediates the increased expression of AChE in high glucose condition: in vitro and in vivo evidences.
Liu YW; Zhang L; Li Y; Cheng YQ; Zhu X; Zhang F; Yin XX
Mol Neurobiol; 2016 Sep; 53(7):4972-80. PubMed ID: 26374551
[TBL] [Abstract][Full Text] [Related]
17. ATP-mediated protein kinase B Akt/mammalian target of rapamycin mTOR/p70 ribosomal S6 protein p70S6 kinase signaling pathway activation promotes improvement of locomotor function after spinal cord injury in rats.
Hu LY; Sun ZG; Wen YM; Cheng GZ; Wang SL; Zhao HB; Zhang XR
Neuroscience; 2010 Sep; 169(3):1046-62. PubMed ID: 20678995
[TBL] [Abstract][Full Text] [Related]
18. Roles of the mammalian target of rapamycin (mTOR) signaling pathway in the repair of hyperoxia-induced acute lung injury.
Wang SH; Li LH; Zou DM; Zheng XM; Deng J
Adv Clin Exp Med; 2020 Jan; 29(1):13-23. PubMed ID: 31782272
[TBL] [Abstract][Full Text] [Related]
19. Increased expression of (immuno)proteasome subunits during epileptogenesis is attenuated by inhibition of the mammalian target of rapamycin pathway.
Broekaart DWM; van Scheppingen J; Geijtenbeek KW; Zuidberg MRJ; Anink JJ; Baayen JC; Mühlebner A; Aronica E; Gorter JA; van Vliet EA
Epilepsia; 2017 Aug; 58(8):1462-1472. PubMed ID: 28643873
[TBL] [Abstract][Full Text] [Related]
20. Saikosaponin a functions as anti-epileptic effect in pentylenetetrazol induced rats through inhibiting mTOR signaling pathway.
Ye M; Bi YF; Ding L; Zhu WW; Gao W
Biomed Pharmacother; 2016 Jul; 81():281-287. PubMed ID: 27261605
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
